Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

doi:10.1084/jem.176.5.1283

This Article

	Full Text (PDF, 669K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Faber, L. M.
	Articles by Falkenburg, J. H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Faber, L. M.
	Articles by Falkenburg, J. H.


Social Bookmarking

	What's this?

ARTICLES

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

LM Faber, SA van Luxemburg-Heijs, R Willemze and JH Falkenburg
Department of Hematology, University Medical Center, Leiden, The Netherlands.

Allogeneic bone marrow transplantation (BMT) has been associated with a graft-vs.-leukemia (GVL) reactivity. Since T cell depletion of the bone marrow graft has decreased the risk of graft-vs.-host disease (GVHD), but has been associated with higher rates of leukemia relapse, GVL reactivity is probably caused by donor-derived T lymphocytes. Previously, we demonstrated that minor histocompatibility (mH) antigen- specific cytotoxic T lymphocyte (CTL) clones, generated from patients after BMT, are capable of major histocompatibility complex-(MHC) restricted lysis of (clonogenic) myeloid leukemic cells. Here, we investigated whether donor-derived leukemia-specific CTL clones can be generated in vitro, before BMT, using irradiated leukemic cells from a patient with acute myeloid leukemia as stimulator cells, and peripheral blood or bone marrow from the HLA genotypically identical sibling donor as responder cells. Several CTL lines were generated that showed specific lysis (> 50%) of the recipient leukemic cells in a 51Cr- release assay. Two of these CTL lines were cloned by limiting dilution in the presence of the irradiated recipient cells. Multiple leukemia- reactive, HLA class I and II-restricted clones with various specificities could be established. These alloreactive, antileukemic CTL clones may cause GVL reactivity after BMT, and may be used as adjuvant immunotherapy in the treatment of leukemia.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

van Bergen, C. A. M., Kester, M. G. D., Jedema, I., Heemskerk, M. H. M., van Luxemburg-Heijs, S. A. P., Kloosterboer, F. M., Marijt, W. A. E., de Ru, A. H., Schaafsma, M. R., Willemze, R., van Veelen, P. A., Falkenburg, J. H. F. (2007). Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene. Blood 109: 4089-4096 [Abstract] [Full Text]
Heemskerk, M. H. M., Hagedoorn, R. S., van der Hoorn, M. A. W. G., van der Veken, L. T., Hoogeboom, M., Kester, M. G. D., Willemze, R., Falkenburg, J. H. F. (2007). Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood 109: 235-243 [Abstract] [Full Text]
Kloosterboer, F. M., van Luxemburg-Heijs, S. A. P., van Soest, R. A., van Egmond, H. M. E., Willemze, R., Falkenburg, J. H. F. (2005). Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia. Blood 106: 3955-3957 [Abstract] [Full Text]
Akatsuka, Y., Nishida, T., Kondo, E., Miyazaki, M., Taji, H., Iida, H., Tsujimura, K., Yazaki, M., Naoe, T., Morishima, Y., Kodera, Y., Kuzushima, K., Takahashi, T. (2003). Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens. JEM 197: 1489-1500 [Abstract] [Full Text]
Nijmeijer, B. A., Willemze, R., Falkenburg, J. H. F. (2002). An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice. Blood 100: 654-660 [Abstract] [Full Text]
Yang, X.-F., Wu, C. J., McLaughlin, S., Chillemi, A., Wang, K. S., Canning, C., Alyea, E. P., Kantoff, P., Soiffer, R. J., Dranoff, G., Ritz, J. (2001). CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 98: 7492-7497 [Abstract] [Full Text]
Hsieh, M. H., Korngold, R. (2000). Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. Blood 96: 1047-1055 [Abstract] [Full Text]
Brenner, M., Rossig, C., Sili, U., Young, J. W., Goulmy, E. (2000). Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy. ASH Education Book 2000: 356-375 [Abstract] [Full Text]
Gao, L., Yang, T.-H., Tourdot, S., Sadovnikova, E., Hasserjian, R., Stauss, H. J. (1999). Allo-Major Histocompatibility Complex-Restricted Cytotoxic T Lymphocytes Engraft in Bone Marrow Transplant Recipients Without Causing Graft-Versus-Host Disease. Blood 94: 2999-3006 [Abstract] [Full Text]
Falkenburg, J.H. F., Wafelman, A. R., Joosten, P., Smit, W. M., van Bergen, C. A.M., Bongaerts, R., Lurvink, E., van der Hoorn, M., Kluck, P., Landegent, J. E., Kluin-Nelemans, H. C., Fibbe, W. E., Willemze, R. (1999). Complete Remission of Accelerated Phase Chronic Myeloid Leukemia by Treatment With Leukemia-Reactive Cytotoxic T Lymphocytes. Blood 94: 1201-1208 [Abstract] [Full Text]
Locatelli, F., Rocha, V., Chastang, C., Arcese, W., Michel, G., Abecasis, M., Messina, C., Ortega, J., Badell-Serra, I., Plouvier, E., Souillet, G., Jouet, J.-P., Pasquini, R., Ferreira, E., Garnier, F., Gluckman, E. (1999). Factors Associated With Outcome After Cord Blood Transplantation in Children With Acute Leukemia. Blood 93: 3662-3671 [Abstract] [Full Text]
Dolstra, H., Fredrix, H., Maas, F., Coulie, P. G., Brasseur, F., Mensink, E., Adema, G. J., de Witte, T. M., Figdor, C. G., van de Wiel-van Kemenade, E. (1999). A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia. JEM 189: 301-308 [Abstract] [Full Text]
van de Corput, L., Kluin-Nelemans, H. C., Kester, M. G.D., Willemze, R., Falkenburg, J.H. F. (1999). Hairy Cell Leukemia-Specific Recognition by Multiple Autologous HLA-DQ or DP-Restricted T-Cell Clones. Blood 93: 251-259 [Abstract] [Full Text]
Mutis, T., Schrama, E., Melief, C. J.M., Goulmy, E. (1998). CD80-Transfected Acute Myeloid Leukemia Cells Induce Primary Allogeneic T-Cell Responses Directed at Patient Specific Minor Histocompatibility Antigens and Leukemia-Associated Antigens. Blood 92: 1677-1684 [Abstract] [Full Text]
Smit, W. M., Rijnbeek, M., van Bergen, C. A.�M., Fibbe, W. E., Willemze, R., Falkenburg, J. H.�F. (1998). T cells recognizing leukemic CD34+ progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc. Natl. Acad. Sci. USA 95: 10152-10157 [Abstract] [Full Text]
Ostankovitch, M., Buzyn, A., Bonhomme, D., Connan, F., Bouscary, D., Heshmati, F., Dreyfus, F., Choppin, J., Guillet, J.-G. (1998). Antileukemic HLA-Restricted T-Cell Clones Generated With Naturally Processed Peptides Eluted From Acute Myeloblastic Leukemia Blasts. Blood 92: 19-24 [Abstract] [Full Text]
Alyea, E. P., Soiffer, R. J., Canning, C., Neuberg, D., Schlossman, R., Pickett, C., Collins, H., Wang, Y., Anderson, K. C., Ritz, J. (1998). Toxicity and Efficacy of Defined Doses of CD4+ Donor Lymphocytes for Treatment of Relapse After Allogeneic Bone Marrow Transplant. Blood 91: 3671-3680 [Abstract] [Full Text]
Osanto, S. (1997). Vaccine Trials for the Clinician: Prospects for Tumor Antigens. The Oncologist 2: 284-299 [Abstract] [Full Text]
Mutis, T., Schrama, E., A.P. van Luxemburg-Heijs, S., Falkenburg, J.H.F, Melief, C. J.M., Goulmy, E. (1997). HLA Class II Restricted T-Cell Reactivity to a Developmentally Regulated Antigen Shared by Leukemic Cells and CD34+ Early Progenitor Cells. Blood 90: 1083-1090 [Abstract] [Full Text]
Cardoso, A. A., Seamon, M. J., Afonso, H. M., Ghia, P., Boussiotis, V. A., Freeman, G. J., Gribben, J. G., Sallan, S. E., Nadler, L. M. (1997). Ex Vivo Generation of Human Anti-Pre-B Leukemia-Specific Autologous Cytolytic T Cells. Blood 90: 549-561 [Abstract] [Full Text]
Barrett, A.J. (1997). Mechanisms of the Graft-versus-Leukemia Reaction. Stem Cells 15: 248-258 [Abstract] [Full Text]